Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 7,925,000 | 7,769,000 | 7,082,000 | 6,667,000 | 7,569,000 |
| Cost of Goods | 1,623,000 | 1,569,000 | 1,501,000 | 1,540,000 | 1,581,000 |
| Gross Profit | 6,302,000 | 6,200,000 | 5,581,000 | 5,127,000 | 5,988,000 |
| Operating Expenses | 4,317,000 | 2,873,000 | 3,107,000 | 2,890,000 | 3,536,000 |
| Operating Income | 1,984,000 | 3,327,000 | 2,474,000 | 2,237,000 | 2,452,000 |
| Interest Expense | 255,000 | 256,000 | 254,000 | 260,000 | 248,000 |
| Other Income | 349,000 | 570,000 | 209,000 | -328,000 | -37,000 |
| Pre-tax Income | 2,078,000 | 3,641,000 | 2,429,000 | 1,649,000 | 2,167,000 |
| Income Tax | -105,000 | 589,000 | 468,000 | 334,000 | 385,000 |
| Net Income Continuous | 2,183,000 | 3,052,000 | 1,961,000 | 1,315,000 | 1,782,000 |
| Net Income | $2,183,000 | $3,052,000 | $1,960,000 | $1,315,000 | $1,783,000 |
| EPS Basic Total Ops | 1.76 | 2.46 | 1.57 | 1.06 | 1.43 |
| EPS Basic Continuous Ops | 1.76 | 2.46 | 1.58 | 1.06 | 1.43 |
| EPS Diluted Total Ops | 1.74 | 2.43 | 1.56 | 1.04 | 1.43 |
| EPS Diluted Continuous Ops | 1.74 | 2.43 | 1.56 | 1.04 | 1.44 |
| EPS Diluted Before Non-Recurring Items | N/A | 2.47 | 2.01 | 1.81 | 1.90 |
| EBITDA(a) | $N/A | $4,013,000 | $3,165,000 | $2,933,000 | $3,145,000 |